Saveria Campisi

Ragusa, 97100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study.

Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study.

Journal: Journal of clinical medicine

Published: July 03, 2025

COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.

COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet.

Journal: Orphanet journal of rare diseases

Published: January 04, 2025

A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence Optimization.

A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies for Adherence Optimization.

Journal: Mediterranean journal of hematology and infectious diseases

Published: November 28, 2024

Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database.

Underlying disease is the main risk factor in post-splenectomy complication risk: Data from a national database.

Journal: British journal of haematology

Published: November 22, 2024

Long-term outcomes of avascular necrosis in sickle cell disease using joint-specific patient-reported outcome measures: Results from a multicentre study.

Long-term outcomes of avascular necrosis in sickle cell disease using joint-specific patient-reported outcome measures: Results from a multicentre study.

Journal: British journal of haematology

Published: July 29, 2024

Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.

Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.

Journal: Frontiers in medicine

Published: December 09, 2021

Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.

Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection.

Journal: American journal of hematology

Published: October 29, 2021

The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.

The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A Network.

Journal: Acta bio-medica : Atenei Parmensis

Published: July 24, 2021

The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A survey.

The Prevalence of glucose dysregulations (GDs) in patients with β-thalassemias in different countries: A preliminary ICET-A survey.

Journal: Acta bio-medica : Atenei Parmensis

Published: May 04, 2021

Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.

Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.

Journal: Haematologica

Published: September 18, 2020

A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we stand.

A comprehensive update of ICET-A Network on COVID-19 in thalassemias: what we know and where we stand.

Journal: Acta bio-medica : Atenei Parmensis

Published: June 18, 2020

Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study.

Preliminary Data on COVID-19 in Patients with Hemoglobinopathies: A Multicentre ICET-A Study.

Journal: Mediterranean journal of hematology and infectious diseases

Published: May 30, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026